Tenax Therapeutics Debt 2024

Tenax Therapeutics Aktienanalyse

What does Tenax Therapeutics do?

Tenax Therapeutics Inc. is a biopharmaceutical company based in Morrisville, North Carolina. It specializes in the development of therapeutics for cardiovascular and pulmonary diseases. The company was founded in 1967 by a group of physicians and scientists. Formerly known as Oxygen Biotherapeutics, it was rebranded as Tenax Therapeutics in 2014. Tenax Therapeutics' business model is focused on the development, manufacturing, and marketing of products for rare diseases. The company aims to develop innovative therapies for severe and life-threatening diseases where there is a high demand for novel treatment options. The focus of Tenax Therapeutics is on cardiovascular and respiratory diseases. The company specializes in the development of medications for the treatment of severe or life-threatening conditions such as cardiogenic shock, pulmonary hypertension, and pulmonary embolism. Over the years, Tenax Therapeutics has established several divisions to streamline its research and development activities. One of the key divisions is clinical research, where the company conducts clinical trials to test the efficacy and safety of its products and obtain regulatory approval. Another pillar of the company is product development, where Tenax Therapeutics develops new compounds and medications to specifically target conditions like cardiogenic shock. Given the high demand for new therapies for rare diseases, the company adopts a highly focused approach and concentrates on developing products for specific indications. Tenax Therapeutics' extensive product portfolio includes various medications and therapeutics that can be used to treat cardiovascular and pulmonary diseases. One important representative in this area is Levosimendan, a vasodilator and inotropic medication used in patients with cardiogenic shock, as well as heart failure and other cardiovascular conditions. Another product in Tenax Therapeutics' portfolio is the active substance ANX-188. This medication is used for the treatment of patients with severe cardiogenic shock and has already been tested in clinical trials. Overall, Tenax Therapeutics aims to develop innovative and effective therapies for rare diseases of the cardiovascular and pulmonary systems. The company strives to address the medical need in this field and ensure high patient satisfaction. Tenax Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Tenax Therapeutics's Debt Structure

Tenax Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Tenax Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Tenax Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Tenax Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Tenax Therapeutics Stock

What is the debt of Tenax Therapeutics this year?

Tenax Therapeutics has a debt level of -9.29 USD this year.

What was the debt of Tenax Therapeutics compared to the previous year?

The debt of Tenax Therapeutics has increased by 519.4% compared to the previous year increased.

What are the consequences of high debt for investors in Tenax Therapeutics?

High debt can pose a risk for investors of Tenax Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Tenax Therapeutics?

Low debt means that Tenax Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Tenax Therapeutics affect the company?

An increase in debt of Tenax Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Tenax Therapeutics affect the company?

A reduction in debt of Tenax Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Tenax Therapeutics?

Some factors that can influence the debt of Tenax Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Tenax Therapeutics so important for investors?

The debts of Tenax Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Tenax Therapeutics take to change the debt?

To change the debt, Tenax Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Tenax Therapeutics pay?

Over the past 12 months, Tenax Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tenax Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Tenax Therapeutics?

The current dividend yield of Tenax Therapeutics is .

When does Tenax Therapeutics pay dividends?

Tenax Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tenax Therapeutics?

Tenax Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Tenax Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tenax Therapeutics located?

Tenax Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Tenax Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tenax Therapeutics from 6/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/30/2024.

When did Tenax Therapeutics pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of Tenax Therapeutics in the year 2023?

In the year 2023, Tenax Therapeutics distributed 0 USD as dividends.

In which currency does Tenax Therapeutics pay out the dividend?

The dividends of Tenax Therapeutics are distributed in USD.